← All patents

US20190234967A1

Blood Test for Screening Out Amyloid and Alzheimers Disease Presence

University of North Texas Health Science Center

Abstract

The present invention includes a method for excluding patients from the need for further analysis of Alzheimer's Disease comprising: obtaining a blood or serum sample from a patient in a primary care setting; determining the expression levels of at least 4 of the following proteins: FABP, beta 2 …

University
University of North Texas Health Science Center
Assignee
University Of North Texas Health Science Center At Fort Worth
Inventor
Sid E. O'Bryant
Priority date
June 22, 2016
Filing date
June 22, 2017
Publication date
August 01, 2019
Language
en
Metadata fetched
August 28, 2026 19:12